Bedtime insulin glargine or bedtime neutral protamine lispro combined with sulfonylurea and metformin in type 2 diabetes. A randomized, controlled trial

Trial Profile

Bedtime insulin glargine or bedtime neutral protamine lispro combined with sulfonylurea and metformin in type 2 diabetes. A randomized, controlled trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Insulin glargine (Primary) ; Insulin neutral protamine lispro (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Oct 2008 Results published in the Annals of Internal Medicine
    • 21 Oct 2008 Primary endpoint 'Proportion of glycosylated haemoglobin' has not been met based on results published in Annals of Internal Medicine.
    • 11 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top